[Promoters of genes MTHFR from patients with hyperhomocysteinemia and PTEN from patients with malignant and benign endometrial and ovarian tumors].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16909866)

Published in Bioorg Khim on August 16, 2006

Authors

T F Kovalenko, O V Vaniusheva, I A Shilov, D V Sosin, A S Sukhoverkhova, T V Kozlova, I N Bokarev, A V Sorokina, L A Ozolinia, L I Patrushev

Articles by these authors

[The A3243G mitochondrial DNA mutation in cerebral artery dissections]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.97

[Morphological signs of mitochondrial cytopathy in skeletal muscles and micro-vessel walls in a patient with cerebral artery dissection associated with MELAS syndrome]. Arkh Patol (2012) 0.96

Functional analysis of LCR sequences from the cut locus of Drosophila melanogaster. Dokl Biochem Biophys (2007) 0.90

[An effective method for site-directed mutagenesis in plasmids and cloning single-stranded DNA fragments]. Bioorg Khim (1991) 0.86

[Effect of renokinase on the space velocity of coronary vein flow during systemic administration to patients with acute myocardial infarct]. Kardiologiia (1988) 0.84

Functions of noncoding sequences in mammalian genomes. Biochemistry (Mosc) (2014) 0.83

Prevalence of genes encoding exfoliative toxins among Staphylococcus hyicus isolated in Russia and Germany. J Vet Med B Infect Dis Vet Public Health (2006) 0.81

[Cloning of the gene for thermostable Thermus aquaticus YT1 DNA polymerase and its expression in Escherichia coli]. Mol Biol (Mosk) (1993) 0.80

The activity of nucleolar organizer regions of human bone marrow cells studied with silver staining. II. Acute leukemia. Cancer Genet Cytogenet (1987) 0.79

[Genomic noncoding sequences and the size of eukaryotic cell nucleus as important factors of gene protection from chemical mutagens]. Bioorg Khim (2007) 0.79

A study of the conditions of the first phosphodiester bond formation by E. coli RNA polymerase. FEBS Lett (1978) 0.78

A new approach for point mutation detection based on a ligase chain reaction. J Biochem Biophys Methods (2001) 0.77

Study of anti-ischemic effect of afobazole in experimental myocardial infarction. Bull Exp Biol Med (2011) 0.77

[New allele-specific primers for detection of Leiden mutation in exon 10 of factor V gene in thrombophilias]. Bioorg Khim (1997) 0.76

[Fibrinogens and their role in atherogenesis in diabetes mellitus]. Klin Med (Mosk) (2007) 0.76

[Nucleolar organizer activity of normal and leukemic cells in human bone marrow]. Tsitologiia (1984) 0.76

[Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias]. Bioorg Khim (2014) 0.75

[Use of urokinase in acute myocardial infarction]. Kardiologiia (1988) 0.75

[Treatment and prevention of iron deficiency anemia in outpatient practice]. Ter Arkh (1998) 0.75

[Effectiveness of unstable angina pectoris treatment by aggregation inhibitors ticlid and aspirin]. Klin Med (Mosk) (1998) 0.75

[Significance of intravascular blood coagulation in the pathogenesis of pregnancy complications]. Akush Ginekol (Mosk) (1977) 0.75

[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease]. Kardiologiia (1978) 0.75

[Effect of insulin and sulfonylurea derivatives on chronic intravascular microcoagulation of the blood in diabetes mellitus]. Sov Med (1985) 0.75

[Comparative evaluation of the effectiveness of peroral treatment of patients with chronic posthemorrhagic anemia with iron-containing preparations]. Klin Med (Mosk) (1975) 0.75

[Modern approaches to the diagnosis of hemorrhagic diathesis]. Lab Delo (1980) 0.75

[Arterial hypertension]. Klin Med (Mosk) (1997) 0.75

[Pharmacological basis of thrombolytic therapy]. Klin Med (Mosk) (1990) 0.75

[New Soviet hemostatic and angioprotective preparation ethamsylate]. Klin Med (Mosk) (1985) 0.75

[Thrombocytic component of hemostasis in chronic nonspecific lung diseases]. Sov Med (1986) 0.75

[Arterial hypertension: is it a disease or a risk factor?]. Klin Med (Mosk) (2004) 0.75

[Chronic intravascular coagulation in diabetic microangiopathy patients]. Klin Med (Mosk) (1985) 0.75

[Prognosis of the course of ischemic heart disease in patients with a history of macrofocal and transmural myocardial infarction in relation to the degree of blood pressure in the pulmonary artery]. Kardiologiia (1989) 0.75

[Ticlid--a new development in the treatment and prevention of arterial thromboses]. Ter Arkh (1992) 0.75

[Telomerase and perspectives of oncohematology]. Klin Med (Mosk) (2001) 0.75

[The current achievements and problems of thrombolytic therapy]. Ter Arkh (1992) 0.75

[Successful gastric resection in a male patient with factor VII deficiency and telangiectasia]. Klin Med (Mosk) (2002) 0.75

[Life-threatening alcoholic hypoglycemia in subjects free of diabetes mellitus]. Klin Med (Mosk) (1999) 0.75

[The soluble fibrin monomer in patients with instable angina]. Klin Med (Mosk) (2005) 0.75

[Effect of ticlopidine on hemostasis in patients with diabetic microangiopathy]. Klin Med (Mosk) (1988) 0.75

[Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components]. Lab Delo (1978) 0.75

[Problems of classification of lymphoproliferative disorders]. Klin Med (Mosk) (1991) 0.75

[Role of the complement system in the pathogenesis and differential diagnosis of different variants of bronchial asthma]. Klin Med (Mosk) (1985) 0.75

[Role of coagulopathies in the pathogenesis of septic shock]. Akush Ginekol (Mosk) (1978) 0.75

[Chronic intravascular blood coagulation in diabetes mellitus]. Klin Med (Mosk) (1982) 0.75

[Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction]. Klin Med (Mosk) (1987) 0.75

[Telomerase--new diagnostic and therapeutic options in oncology]. Voen Med Zh (2000) 0.75

[Role of the system of hemostasis in the pathogenesis of rheumatoid arthritis]. Ter Arkh (1975) 0.75

[Characteristics of changes in the Willebrand factor in patients with ischemic heart disease]. Kardiologiia (1988) 0.75

[Methods of diagnosis in thrombocytopathies]. Lab Delo (1976) 0.75

[Thrombophilic conditions and their clinical aspects]. Klin Med (Mosk) (1991) 0.75

[Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders]. Ter Arkh (1981) 0.75

[Interaction of the complement system with the main components of hemostasis]. Gematol Transfuziol (1985) 0.75

[Disorders of hemostasis and fibrinolysis in hemorrhagic erysipelas]. Sov Med (1989) 0.75

[The effect of fibrinolysin and streptokinase preparations on the course and prognosis of acute myocardial infarction]. Klin Med (Mosk) (1991) 0.75

[Role of cordarone in the treatment of paroxysmal supraventricular tachyarrhythmia in pre-excitation syndrome]. Klin Med (Mosk) (1994) 0.75

[Differential diagnosis of coma in the therapeutic practice]. Sov Med (1991) 0.75

[The activity of Willebrand factor--glycoproteins IIb/IIIa complex in patients with coronary and low extremity arterial atherothrombosis and type 2 diabetes mellitus]. Klin Med (Mosk) (2007) 0.75

[Use of chromogenic peptide substrates in laboratory diagnosis]. Lab Delo (1981) 0.75

[Atherothrombosis and acute coronary syndrome]. Klin Med (Mosk) (2005) 0.75

[Thrombus precursor protein (soluble monomeric protein) in patients with acute coronary syndrome]. Klin Med (Mosk) (2006) 0.75

[Anticoagulant therapy with antivitamins K]. Klin Med (Mosk) (1984) 0.75

[Clinico-hematological characteristics of preleukemia]. Ter Arkh (1984) 0.75

[Current status and problems of anticoagulant therapy]. Klin Med (Mosk) (1980) 0.75

[Comparison of myocardial effects of various antirheumatic modalities in patients with rheumatoid arthritis (prospective clinico-echocardiographic study)]. Klin Med (Mosk) (1997) 0.75

[Complications of verospirone therapy]. Klin Med (Mosk) (1987) 0.75

[The effect of antiaggregants on the course of diabetic microangiopathy]. Ter Arkh (1993) 0.75

[Involvement of the internal organs in chronic alcoholism]. Klin Med (Mosk) (1988) 0.75

[The diagnosis of prognostically unfavorable variants of the premature ventricular excitation syndrome]. Ter Arkh (1997) 0.75

[Hemorrhagic diathesis]. Klin Med (Mosk) (1989) 0.75

[Hypertensic crises]. Klin Med (Mosk) (2005) 0.75

[Specific prevention of postoperative thrombosis in oncology patients]. Khirurgiia (Mosk) (1982) 0.75

[Treatment of thrombocytopenias]. Klin Med (Mosk) (1999) 0.75

[Chronic intravascular microcoagulation of the blood in ischemic heart disease]. Sov Med (1980) 0.75

[Role of intravascular blood coagulation in the pathogenesis of postoperative pneumonia in patients with lung cancer]. Anesteziol Reanimatol (1978) 0.75

[Thrombocytopenias]. Klin Med (Mosk) (1999) 0.75

[Lung diseases and hemostasis]. Klin Med (Mosk) (1986) 0.75

[Detection of soluble fibrin monomer complexes and of platelet factor 4 in the plasma of patients with diabetes mellitus]. Folia Haematol Int Mag Klin Morphol Blutforsch (1979) 0.75

[Treatment of ischemic heart disease with mikristin]. Sov Med (1979) 0.75

[Syndrome of disseminated intravascular coagulation]. Sov Med (1978) 0.75

[Clinical aspects of control in therapy with platelet inhibitors]. Folia Haematol Int Mag Klin Morphol Blutforsch (1979) 0.75

[Carbohydrate exchange in patients with acute coronary syndrome]. Klin Med (Mosk) (2007) 0.75

[Fibrinolytic activity of rat blood during transient coronary insufficiency]. Biull Eksp Biol Med (1987) 0.75

[Antiphospholipid syndrome: modern problems]. Klin Med (Mosk) (2007) 0.75

[Atherothrombosis: state-of-the-art review and approaches to the problem]. Klin Med (Mosk) (2008) 0.75

[Value of various coagulation studies in the diagnosis of thromboses]. Kardiologiia (1974) 0.75

[Heart failure: limits of classification]. Klin Med (Mosk) (1998) 0.75

[I. I. Mechnikov and the Kherson sanitary organization]. Zh Mikrobiol Epidemiol Immunobiol (1965) 0.75

[Diagnosis and prevention of postoperative thromboembolic complications]. Khirurgiia (Mosk) (1986) 0.75

[Current problems in the diagnosis and treatment of ventricular pre-excitation syndrome and its complications]. Klin Med (Mosk) (1991) 0.75

[Permanent and disseminated intravascular coagulation]. Klin Med (Mosk) (2000) 0.75

[Thrombophilia, venous thromboses and their treatment]. Klin Med (Mosk) (2002) 0.75

[DIC syndrome: current views and problems]. Klin Med (Mosk) (1992) 0.75

[Condition of hemostasis in the hemorrhagic syndrome of erysipelas patients]. Klin Med (Mosk) (1986) 0.75

[Importance of a determining fibrinogen derivatives in physiological pregnancy and in pregnancy complicated by nephropathy]. Akush Ginekol (Mosk) (1978) 0.75

[Effect of ticlopidine on the course of diabetic microangiopathy]. Sov Med (1988) 0.75

[Diagnostic and therapeutic problems in adult onset Still's disease (data of a long-term follow-up)]. Klin Med (Mosk) (2002) 0.75